Other Events ·
On September 3, 2026, KALA BIO, Inc. entered into an Exclusive Distribution and Reseller Agreement with Virotek, Inc.…
KALAKALA BIO, Inc.
On September 3, 2026, KALA BIO, Inc. entered into an Exclusive Distribution and Reseller Agreement with Virotek, Inc., appointing Kala as the sole exclusive distributor and reseller of a genetic testing and screening program for ophthalmology in the United States. The agreement has an initial term of five years, contingent on Kala achieving specific milestones by September 3, 2027; failure to meet these milestones converts the appointment from exclusive to non-exclusive. Net profits are split equally between the parties after Virotek recovers its cost of goods sold. KALA BIO, Inc. operates in the biotechnology industry, focusing on developing therapies for rare eye diseases.